Skip to contentC
Chemed Corp
C
CHEChemed Corp Q1 2020 · 10-Q
Revenue$515.80M$515.80M+11.6% vs Q1 2019 Net Income$55.89M$55.89M+25.1% vs Q1 2019 EPS Diluted$3.38$3.38+25.2% vs Q1 2019 Operating Income$79,363,000+60.4% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemed Corp · CIK 19584 · Engraved from SEC EDGAR
Free Cash Flowderived$69,429,000+16.3% Margins · derivedOperating margin15.4%+4.7 pt vs Q1 2019
Net margin10.8%+1.2 pt vs Q1 2019
ended Mar 31, 2020 · filed May 1, 2020 · 31 d after period end